Mascoma Wealth Management »

Crispr Therapeutics shares owned by Mascoma Wealth Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mascoma Wealth Management from 13F filings

Historical chart of Mascoma Wealth Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Mascoma Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Mascoma Wealth Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.8k 41 68.17
2023-12-31 $2.6k 41 62.61
2023-09-30 $1.9k 41 45.39
2023-06-30 $2.2k 41 53.05
2023-03-31 $14k 291 48.94
2022-12-31 $12k 291 40.65
2022-09-30 $16k 250 64.00
2022-06-30 $15k 250 60.00
2022-03-31 $16k 250 64.00